Detalhe da pesquisa
1.
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study.
Haematologica
; 103(7): 1209-1217, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29674504
2.
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.
Hematol Oncol
; 2018 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29602219
3.
Continuous treatment with Ibrutinib in 100 untreated patients with TP53 disrupted chronic lymphocytic leukemia: A real-life campus CLL study.
Am J Hematol
; 97(3): E95-E99, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904743
4.
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model.
Am J Hematol
; 97(5): E176-E180, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170793
5.
Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience.
Br J Haematol
; 187(1): e8-e11, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364153
6.
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients.
Am J Hematol
; 89(5): 480-6, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24415640
7.
Eosinophilic dermatosis of hematologic malignancy: A retrospective cohort of 37 patients from an Italian center.
J Am Acad Dermatol
; 81(1): 246-249, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30528498
8.
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment.
Eur J Haematol
; 2018 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30039576
9.
Effects on bone metabolism of new therapeutic strategies with standard chemotherapy and biologic drugs.
Clin Cases Miner Bone Metab
; 10(3): 183-6, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24554928
10.
An Italian retrospective study on the routine clinical use of low-dose alemtuzumab in relapsed/refractory chronic lymphocytic leukaemia patients.
Br J Haematol
; 156(4): 481-9, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22150204
11.
Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients: correlation with biologically-based risk stratification.
Haematologica
; 102(9): e352-e355, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28596282
12.
Multiple myeloma.
Clin Cases Miner Bone Metab
; 9(3): 150-2, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23289028
13.
The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.
Am J Hematol
; 86(12): 1007-12, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21953617
14.
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib.
Cancers (Basel)
; 13(13)2021 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34209515
15.
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib?
Blood Adv
; 5(24): 5490-5500, 2021 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525181
16.
Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA.
Eur J Haematol
; 84(3): 223-8, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19930441
17.
Systemic mastocytosis with skeletal involvement: a case report and review of the literature.
Clin Cases Miner Bone Metab
; 6(1): 66-70, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22461100
18.
The addition of liposomal doxorubicin to bortezomib, thalidomide and dexamethasone significantly improves clinical outcome of advanced multiple myeloma.
Br J Haematol
; 141(6): 814-9, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18410447
19.
Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia.
Cancer Genet Cytogenet
; 176(1): 67-71, 2007 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17574967
20.
Combination of bendamustine and rituximab as front-line therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials.
Eur J Cancer
; 60: 154-65, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27127905